Understanding how malaria is imported and spread in Zanzibar
Importation and transmission of malaria in Zanzibar: a case study for elimination
This study is looking at how malaria comes back to the Zanzibar Archipelago and spreads, and it involves collecting samples from people with malaria to help figure out where the disease is coming from and how travel affects its spread.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10891570 on NIH RePORTER |
What this research studies
This research investigates the importation and transmission of malaria in the Zanzibar Archipelago, focusing on understanding the factors that contribute to malaria re-introduction and local transmission. By combining genomic studies with ongoing surveillance and case detection efforts, the research aims to identify sources of imported malaria cases and model the relationship between human travel and parasite genetics. Patients will be involved through the collection of samples from reported malaria cases, which will help in understanding the dynamics of malaria transmission in the region.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with malaria in Zanzibar or those who have traveled to and from the region.
Not a fit: Patients who do not have malaria or are not connected to the Zanzibar region may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for malaria elimination in Zanzibar and similar regions.
How similar studies have performed: Previous research has shown success in using genomic approaches to track malaria transmission, indicating that this methodology is promising.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Juliano, Jonathan J — Univ of North Carolina Chapel Hill
- Study coordinator: Juliano, Jonathan J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.